Management of Differentiated Thyroid Cancer

This text provides a comprehensive, state-of-the art review of this field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in thyroid cancer. The book reviews new data about molecular genetics and molecular diagnostic approaches, covers diagnosis and treatment of localized disease, and conventional and newer therapies for dealing with recurrent and metastatic disease. Areas of controversy, with expert opinions from both outlooks, are also covered.  

Management of Differentiated Thyroid Cancer serves as a very useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy.  It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information.

The Rising Incidence of Thyroid Cancer: Contributions from Healthcare Practice and Biologic Risk Factors.- Molecular Genetics of Thyroid Cancer.- Evaluation of a thyroid nodule.- Pathologic diagnosis of thyroid cancer.- Molecular Diagnostic Approaches and their Clinical Utility.- Clinical Presentation and Diagnosis of Papillary Thyroid Cancer.- Clinical Presentation and Diagnosis of Follicular Thyroid Cancer.- Clinical Presentation and Diagnosis of Hürthle cell Thyroid Cancer.- High Risk and Poorly Differentiated Thyroid Cancer.- Pediatric Thyroid Cancer.- Active Surveillance as the Initial Course of Action in low-risk papillary microcarcinoma.- Surgical treatment of papillary and follicular thyroid cancer.- Lymph node dissection for differentiated thyroid cancer.- The Debate For Elective Lymph Node Dissection in Papillary Thyroid Carcinoma.- Debate:  Pro and Con Elective Lymph Node Dissection.- Differentiated Thyroid Cancer – Prognostic and Risk Assessment Systems.- Radioactive Iodine as Adjuvant or Systemic Treatment.- Considerations in thyrotropin stimulating hormone suppression in individuals with differentiated thyroid cancer.- IMAGING MODALITIES IN THE DIAGNOSIS OF RECURRENT OR METASTATIC THYROID CANCER.- Operative Treatment of Recurrent or Metastatic Disease.- Local and Systemic Treatment of Unresectable Disease.- Surveillance Strategies After Initial Treatment of Differentiated Thyroid Cancer.

Anne T Mancino, M.D., F.A.C.S.

Associate Professor, Department of Surgery

University of Arkansas

Chief, General Surgery

Central Arkansas Veterans Healthcare System

Little Rock, AR 

USA

Lawrence T. Kim, M.D., F.A.C.S.

Professor, Division of Surgical Oncology, Department of Surgery

University of North Carolina

170 Manning Drive

1150 Physicians Office Building, CB#7213

Chapel Hill, NC

USA